Selected article for: "defense line and viral infection"
Author: Zong, Zhi; Zhang, Zhengkui; Wu, Liming; Zhang, Long; Zhou, Fangfang
Title: The Functional Deubiquitinating Enzymes in Control of Innate Antiviral Immunity
  • Cord-id: 057yy33u
  • Document date: 2020_12_15
    • ID: 057yy33u
    Snippet: Innate antiviral immunity is the first line of host defense against invading viral pathogens. Immunity activation primarily relies on the recognition of pathogen‐associated molecular patterns (PAMPs) by pattern recognition receptors (PRRs). Viral proteins or nucleic acids mainly engage three classes of PRRs: Toll‐like receptors (TLRs), retinoic acid‐inducible gene I (RIG‐I)‐like receptors (RLRs), and DNA sensor cyclic GMP‐AMP (cGAMP) synthase (cGAS). These receptors initiate a series
    Document: Innate antiviral immunity is the first line of host defense against invading viral pathogens. Immunity activation primarily relies on the recognition of pathogen‐associated molecular patterns (PAMPs) by pattern recognition receptors (PRRs). Viral proteins or nucleic acids mainly engage three classes of PRRs: Toll‐like receptors (TLRs), retinoic acid‐inducible gene I (RIG‐I)‐like receptors (RLRs), and DNA sensor cyclic GMP‐AMP (cGAMP) synthase (cGAS). These receptors initiate a series of signaling cascades that lead to the production of proinflammatory cytokines and type I interferon (IFN‐I) in response to viral infection. This system requires precise regulation to avoid aberrant activation. Emerging evidence has unveiled the crucial roles that the ubiquitin system, especially deubiquitinating enzymes (DUBs), play in controlling immune responses. In this review, an overview of the most current findings on the function of DUBs in the innate antiviral immune pathways is provided. Insights into the role of viral DUBs in counteracting host immune responses are also provided. Furthermore, the prospects and challenges of utilizing DUBs as therapeutic targets for infectious diseases are discussed.

    Search related documents:
    Co phrase search for related documents
    • active site and additional domain: 1, 2, 3
    • active site and long sense: 1
    • active site and low affinity: 1, 2, 3, 4, 5, 6
    • active site and lysine residue: 1, 2
    • active site and lysine site: 1, 2
    • acute respiratory syndrome and adaptor protein: 1, 2, 3, 4, 5
    • acute respiratory syndrome and additional domain: 1, 2
    • acute respiratory syndrome and long sense: 1, 2, 3, 4, 5, 6
    • acute respiratory syndrome and long term resistance: 1
    • acute respiratory syndrome and low affinity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • acute respiratory syndrome and lps induce: 1, 2, 3, 4, 5, 6, 7, 8
    • acute respiratory syndrome and lps response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute respiratory syndrome and lps treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • acute respiratory syndrome and lubac assembly complex: 1, 2
    • acute respiratory syndrome and lupus erythematosus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70
    • acute respiratory syndrome and lysine residue: 1, 2, 3, 4, 5
    • acute respiratory syndrome and lysine site: 1, 2, 3
    • acute respiratory syndrome and lytic infection: 1, 2, 3